Skip to content

Scleroderma Treatment & Research Program

Scleroderma Foundation logo (Opens in a new window) (Opens in a new window) (Opens in a new window)Scleroderma is a rare, autoimmune disease that causes thickening and hardening of skin and connective tissue. Systemic (system-wide) scleroderma also can damage blood vessels, muscles, joints and internal organs like the esophagus, lungs, heart, gastrointestinal tract and kidneys.

Though there is not yet a cure for scleroderma, there are treatments to help with symptom management.

The Scleroderma Treatment & Research Program at National Jewish Health in Denver, Colorado, is a designated Scleroderma Research & Treatment Center (DSRTC) (Opens in a new window) (Opens in a new window) (Opens in a new window). Our multidisciplinary team includes specialists in rheumatology, interstitial lung disease, pulmonary hypertension, cardiology, gastroenterology and nephrology, ensuring our patients receive comprehensive care. Our scleroderma treatments are supported by clinical and translational research to help provide the most up-to-date therapies for our patients.


Scleroderma Care at National Jewish Health

The Scleroderma Treatment and Research Program provides comprehensive care for patients with scleroderma and related conditions. The treatment program includes:

  • Advanced diagnostic and treatment options for scleroderma
  • Individualized care plans
  • Access to the latest scleroderma clinical trials
  • Nutritional counseling
  • Specialized pulmonary and physical rehabilitation programs
  • Patient education and support groups

For information regarding referrals, please contact


Conditions Treated


Related Programs

We are currently accepting new patients. To schedule an appointment, call 877.225.5654 or make an appointment.

Clinical Trials and Research

Our scientists and clinicians engage in laboratory, translational and clinical research projects to continually improve our treatment programs. We have clinical trials open for volunteers. If you are interested in participating in a clinical trial, contact Cynthia Wainscoat at 303.398.1259 or View all of our currently available clinical trials below:


  • Arash Babaei

    Arash Babaei, MD

  • Andrew M. Freeman

    Andrew M. Freeman, MD, FACC, FACP

  • Marjorie Patricia George

    Marjorie Patricia George, MD

  • Rebecca C. Keith

    Rebecca C. Keith, MD

  • Darlene Kim

    Darlene Kim, MD, FACC

  • Tim Lahm

    Tim Lahm, MD, ATSF

  • Adriel J. Malavé

    Adriel J. Malavé, MD

  • Mehrnaz Maleki Fischbach

    Mehrnaz Maleki Fischbach, MD

  • Michael P. Mohning

    Michael P. Mohning, MD

  • Kevin Rurak

    Kevin Rurak, MD

  • Smarika Sapkota

    Smarika Sapkota, MD

  • Jeff Swigris

    Jeff Swigris, DO, MS

  • Zulma X. Yunt

    Zulma X. Yunt, MD

Reasons to Choose National Jewish Health

  • The leading respiratory hospital in the nation and the only one devoted fully to the treatment of respiratory and related illnesses
  • Ranked #1 or #2 in Pulmonology by U.S. News & World Report for 26 consecutive years
  • Ranked in the top 5% of hospitals in the nation by HCAHPS
  • Physicians consistently recognized among the best in the nation by multiple services, including Best Doctors in America and Castle Connolly
  • Among the top 6% of organizations funded for research by the NIH, providing patients access to hundreds of active clinical trials
  • 124-year history of focus on care, research and education serving patients from around the world with lung, heart, immune and related disorders
Make an Appointment